287 related articles for article (PubMed ID: 16507993)
1. Regulation of cellular immortalization and steady-state levels of the telomerase reverse transcriptase through its carboxy-terminal domain.
Middleman EJ; Choi J; Venteicher AS; Cheung P; Artandi SE
Mol Cell Biol; 2006 Mar; 26(6):2146-59. PubMed ID: 16507993
[TBL] [Abstract][Full Text] [Related]
2. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
[TBL] [Abstract][Full Text] [Related]
3. Telomeric function of mammalian telomerases at short telomeres.
Fakhoury J; Marie-Egyptienne DT; Londoño-Vallejo JA; Autexier C
J Cell Sci; 2010 May; 123(Pt 10):1693-704. PubMed ID: 20427319
[TBL] [Abstract][Full Text] [Related]
4. An intact putative mouse telomerase essential N-terminal domain is necessary for proper telomere maintenance.
Rousseau P; Khondaker S; Zhu S; Lauzon C; Mai S; Autexier C
Biol Cell; 2016 Apr; 108(4):96-112. PubMed ID: 26787169
[TBL] [Abstract][Full Text] [Related]
5. Telomerase reverse transcriptase expression protects transformed human cells against DNA-damaging agents, and increases tolerance to chromosomal instability.
Fleisig HB; Hukezalie KR; Thompson CA; Au-Yeung TT; Ludlow AT; Zhao CR; Wong JM
Oncogene; 2016 Jan; 35(2):218-27. PubMed ID: 25893297
[TBL] [Abstract][Full Text] [Related]
6. Differential cis-regulation of human versus mouse TERT gene expression in vivo: identification of a human-specific repressive element.
Horikawa I; Chiang YJ; Patterson T; Feigenbaum L; Leem SH; Michishita E; Larionov V; Hodes RJ; Barrett JC
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18437-42. PubMed ID: 16344462
[TBL] [Abstract][Full Text] [Related]
7. The N-terminus of hTERT contains a DNA-binding domain and is required for telomerase activity and cellular immortalization.
Sealey DC; Zheng L; Taboski MA; Cruickshank J; Ikura M; Harrington LA
Nucleic Acids Res; 2010 Apr; 38(6):2019-35. PubMed ID: 20034955
[TBL] [Abstract][Full Text] [Related]
8. Phenotypes in mTERT⁺/⁻ and mTERT⁻/⁻ mice are due to short telomeres, not telomere-independent functions of telomerase reverse transcriptase.
Strong MA; Vidal-Cardenas SL; Karim B; Yu H; Guo N; Greider CW
Mol Cell Biol; 2011 Jun; 31(12):2369-79. PubMed ID: 21464209
[TBL] [Abstract][Full Text] [Related]
9. Regulation of telomere length and homeostasis by telomerase enzyme processivity.
D'Souza Y; Lauzon C; Chu TW; Autexier C
J Cell Sci; 2013 Jan; 126(Pt 2):676-87. PubMed ID: 23178942
[TBL] [Abstract][Full Text] [Related]
10. Strict control of telomerase activation using Cre-mediated inversion.
Ungrin MD; Harrington L
BMC Biotechnol; 2006 Feb; 6():10. PubMed ID: 16504006
[TBL] [Abstract][Full Text] [Related]
11. The structure and function of telomerase reverse transcriptase.
Autexier C; Lue NF
Annu Rev Biochem; 2006; 75():493-517. PubMed ID: 16756500
[TBL] [Abstract][Full Text] [Related]
12. Putative telomere-recruiting domain in the catalytic subunit of human telomerase.
Armbruster BN; Etheridge KT; Broccoli D; Counter CM
Mol Cell Biol; 2003 May; 23(9):3237-46. PubMed ID: 12697823
[TBL] [Abstract][Full Text] [Related]
13. Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells.
Takakura M; Kyo S; Inoue M; Wright WE; Shay JW
Mol Cell Biol; 2005 Sep; 25(18):8037-43. PubMed ID: 16135795
[TBL] [Abstract][Full Text] [Related]
14. An anchor site-type defect in human telomerase that disrupts telomere length maintenance and cellular immortalization.
Moriarty TJ; Ward RJ; Taboski MA; Autexier C
Mol Biol Cell; 2005 Jul; 16(7):3152-61. PubMed ID: 15857955
[TBL] [Abstract][Full Text] [Related]
15. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
Babizhayev MA; Yegorov YE
J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
[TBL] [Abstract][Full Text] [Related]
16. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
17. The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity.
Huard S; Moriarty TJ; Autexier C
Nucleic Acids Res; 2003 Jul; 31(14):4059-70. PubMed ID: 12853623
[TBL] [Abstract][Full Text] [Related]
18. A translocation-defective telomerase with low levels of activity and processivity stabilizes short telomeres and confers immortalization.
D'Souza Y; Chu TW; Autexier C
Mol Biol Cell; 2013 May; 24(9):1469-79. PubMed ID: 23447707
[TBL] [Abstract][Full Text] [Related]
19. RNA binding domain of telomerase reverse transcriptase.
Lai CK; Mitchell JR; Collins K
Mol Cell Biol; 2001 Feb; 21(4):990-1000. PubMed ID: 11158287
[TBL] [Abstract][Full Text] [Related]
20. Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions.
Bachand F; Autexier C
Mol Cell Biol; 2001 Mar; 21(5):1888-97. PubMed ID: 11238925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
